Domů › Rakovina endometria › New York › New York City
Klinické studie Rakovina endometria v New York City, NY
52 studií pro Rakovina endometria hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Probíhá náborFáze 3
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- a dalších 3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of PHST001 in Advanced Solid Tumors
Probíhá náborFáze 1
- Mount Sinai, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Memorial Sloan Kettering Hospital, New York
Study of AVZO-021 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, New York
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Probíhá náborFáze 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Probíhá nábor
- Memorial Sloan Kettering Cancer Center, New York
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Probíhá náborFáze 1
- Research Site, New York
- Research Site, New York
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Probíhá náborFáze 2
- Mount Sinai Chelsea, New York
- Mount Sinai Hospital, New York
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Probíhá náborFáze 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Probíhá náborFáze 3
- NYU Langone Health, New York
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Probíhá náborFáze 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York
- Memorial Sloan Kettering Cancer Center ( Site 6053), New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Probíhá náborFáze 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Probíhá náborFáze 3
- NYU Laura and Isaac Perlmutter Cancer Center - 34th Street, New York
- Perlmutter CC NYU Langone LI, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Probíhá náborFáze 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Probíhá náborFáze 3
- Research Site, New York
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Probíhá náborFáze 1
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Probíhá náborFáze 1
- Icahn School of Medicine at Mount Sinai, New York
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Probíhá náborFáze 2
- Laura & Isaac Perlmutter Cancer Center, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Mount Sinai Health System, New York
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Probíhá náborObservační studie
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Probíhá náborFáze 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- NYP/Weill Cornell Medicine, New York
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Probíhá náborFáze 1/2
- New York University Langone Health, New York
- ICHAN School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
Probíhá náborRaná fáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4175408 in Participants With Advanced Cancer
Probíhá náborFáze 1
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Probíhá náborRaná fáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
Probíhá nábor
- Memorial Sloan Kettering Cancer Center, New York
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, New York
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Probíhá náborFáze 1/2
- NYU Langone Health, New York
Comprehensive Outcomes for After Cancer Health
Probíhá náborVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Cancer Center, New York
Studie Rakovina endometria v jiných městech
- Houston, TX68 studií
- Boston, MA50 studií
- Arlington, VA39 studií
- Nashville, TN38 studií
- Los Angeles, CA34 studií
- St. Louis, MO29 studií
- Philadelphia, PA28 studií
- San Antonio, TX27 studií
- Columbus, OH25 studií
- Chicago, IL25 studií
- Oklahoma City, OK25 studií
- Queens, NY25 studií
Další studie v New York City
- Rakovina prsu136 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)109 studií
- Rakovina prostaty103 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků69 studií
- Rakovina plic60 studií
- Mnohočetný myelom60 studií
- Rakovina slinivky břišní60 studií
- Akutní myeloidní leukemie51 studií
- Srdeční selhání51 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.